Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MORRIS PLAINS, N.J., Feb. 4, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...
-
CUMBERLAND, R.I., Feb. 4, 2011 (GLOBE NEWSWIRE) -- Onset Therapeutics, a PreCision Dermatology company and a leader in the development and commercialization of novel, prescription products for the...
-
SOUTH SAN FRANCISCO, Calif., Feb. 4, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
-
Phase 1 Clinical Data Published by Molecular Cancer Therapeutics Pre-Clinical, Phase 1 and 2 Clinical Data Review Published by Drugs of the Future SALT LAKE CITY, Feb. 3, 2011 (GLOBE NEWSWIRE)...
-
TAMPA, Fla., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Feb. 6-12 is Burn Awareness Week, and during this week, Shriners Hospitals for Children® will kick-off a year-long campaign focused on preventing...
-
CHARLESTON, S.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) presented at the FSX (Financial Services Exchange) "Connect for...
-
BRISBANE, Calif., Feb. 2, 2011 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported...
-
GAITHERSBURG, Md., Feb. 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), ("the Company" or "Cytomedix") a leading developer of biologically active regenerative therapies for wound care,...
-
LOS ANGELES, Feb. 2, 2011 (GLOBE NEWSWIRE) -- CompuMed, Inc. (OTCBB:CMPD) (http://www.compumed.net), a telemedicine and medical informatics company, has entered into an agreement with The Saban Free...
-
LYON, France, Feb. 2, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today it has been granted a special temporary reimbursement for...